Vibrio vulnificus damages macrophages during the early phase of infection

Infection and Immunity

Volumn 75, Issue 9, 2007, Pages 4592-4596

  Tsuchiya, Takahiro ^a   Mitsuo, Eriko ^a   Hayashi, Nahoko ^a   Hikita, Yuuko ^a   Nakao, Hiroshi ^b   Yamamoto, Shigeo ^c   Miyamoto, Katsushiro ^a   Tsujibo, Hiroshi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c MATSUYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELL DAMAGE; CONTROLLED STUDY; DISEASE COURSE; ESTUARINE SPECIES; FEMALE; GRAM NEGATIVE INFECTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS JCM3731; VIBRIO VULNIFICUS M2799;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MACROPHAGES; MICE; MICE, INBRED BALB C; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 34548479547     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00481-07     Document Type: Article

References (33)

1. Brennt, C., A. C. Wright, S. K. Dutta, and J. G. Morris, Jr. 1991. Growth of Vibrio vulnificus in serum from alcholics: association with high transferring iron saturation. J. Infect. Dis. 164:1030-1032.
2. Bullen, J. J., P. B. Spalding, C. G. Ward, and J. M. Gutteridge. 1991. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch. Intern. Med. 151:1606-1609.
3. Chatzidaki-Livanis, M., M. K. Jones, and A. C. Wright. 2006. Genetic variation in the Vibrio vulnificus group 1 capsular polysaccharide operon. J. Bacteriol. 188:1987-1998.
4. Fantuzzi, G., and C. A. Dinarello. 1999. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J. Clin. Immunol. 19:1-11.
5. Fink, S. L., and B. T. Cookson. 2006. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell. Microbiol. 8:1812-1825.
6. Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozoren, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, E. P. Grant, and G. Nunez. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7:576-582.
7. Gray, L. D., and A. S. Kreger. 1985. Purification and characterization of an extracellular cytolysin production by Vibrio vulnificus. Infect. Immun. 48:62-72.
8. Hlady, W. G., and K. C. Klontz. 1996. The epidemiology of vibrio infections in Florida, 1981-1993. J. Infect. Dis. 173:1176-1183.
9. Hotchkiss, R. S., K. C. Chang, P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, R. Aspiotis, Y. Han, D. W. Nicholson, and I. E. Karl. 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1:496-501.
10. + T lymphocytes in humans. J. Immunol. 166:6952-6963.
11. Kashimoto, T., S. Ueno, M. Hanajima, H. Hayashi, Y. Akeda, S. Miyoshi, T. Hongo, T. Honda, and N. Susa. 2003. Vibrio vulnificus induces macrophage apoptosis in vitro and in vivo. Infect. Immun. 71:533-535.
12. Kashimoto, T., S. Ueno, H. Hayashi, M. Hanajima, K. Yoshioka, K. Yoshida, K. Mutoh, and N. Susa. 2005. Depletion of lymphocytes, but not neutrophils, via apoptosis in a murine model of Vibrio vulnificus infection. J. Med. Microbiol. 54:15-22.
13. Kitaura, T., S. Doke, I. Azuma, M. Imaida, K. Miyano, K. Harada, and E. Yabuuchi. 1983. Halo production by sulfatase activity of V. vulnificus and V. cholerae O1 on a new selective sodium dodecyl sulfate-containing agar medium: a screening marker in environmental surveillance. FEMS Microbiol. Lett. 17:205-209.
14. Kothary, M. H., and A. S. Kreger. 1987. Purification and characterization of an elastolytic protease of Vibrio vulnificus. J. Gen. Microbiol. 133:1783-1791.
15. Kraffert, C. A., and D. J. Hogan. 1992. Vibrio vulnificus infection and iron overload. J. Am. Acad. Dermatol. 26:140.
16. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld, E. Towne, D. Tracey, S. Wardwell, F. Wei, W. Wong, R. Kamen, and T. Seshadri. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401-411.
17. Linkous, D. A., and J. D. Oliver. 1999. Pathogenesis of Vibrio vulnificus. FEMS Microbiol. Lett. 174:207-214.
18. Litwin, C. M., T. W. Rayback, and J. Skinner. 1996. Role of catechol siderophore synthesis in Vibrio vulnificus virulence. Infect. Immun. 64:2834-2838.
19. Miyoshi, N., C. Shimizu, S. Miyoshi, and S. Shinoda. 1987. Purification and characterization of Vibrio vulnificus protease. Microbiol. Immunol. 31:13-25.
20. Molofsky, A. B., L. M. Shetron-Rama, and M. S. Swanson. 2005. Components of the Legionella pneumophila flagellar regulon contribute to multiple virulence traits, including lysosome avoidance and macrophage death. Infect. Immun. 73:5720-5734.
21. Molofsky, A. B., B. G. Byrne, N. N. Whitfield, C. A. Madigan, E. T. Fuse, K. Tateda, and M. S. Swanson. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med. 203:1093-1104.
22. Muench, K. H. 1989. Hemochromatosis and infection: alchol and iron, oysters and sepsis. Am. J. Med. 87:40N-43N.
23. Shinoda, S., S. Miyoshi, H. Yamanaka, and N. Miyoshi-Nakahara. 1985. Some properties of Vibrio vulnificus hemolysin. Microbiol. Immunol. 29:583-590.
24. Shinoda, S., M. Kobayashi, H. Yamada, S. Yoshida, M. Ogawa, and M. Mizuguchi. 1987. Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum. Microbiol. Immunol. 31:393-401.
25. Simpson, L. M., V. K. White, S. F. Zane, and J. D. Oliver. 1987. Correlation between virulence and colony morphology in Vibrio culnificus. Infect. Immun. 55:269-272.
26. Starks, A. M., T. R. Schoeb, M. L. Tamplin, S. Parveen, T. J. Doyle, P. E. Bomeisl, G. M. Escudero, and P. A. Gulig. 2000. Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice. Infect. Immun. 68:5785-5793.
27. Stelma, G. N., Jr., A. L. Reyes, J. T. Peeler, C. H. Johnson, and P. L. Spaulding. 1992. Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus. Appl. Environ. Microbiol. 58:2776-2782.
28. Strom, M. S., and R. N. Paranjpye. 2000 Epidemiology and pathogenesis in Vibrio vulnificus. Microbes Infect. 2:177-188.
29. Tamplin, M. L., S. Specter, G. E. Rodrick, and H. Friedman. 1985. Vibrio vulnificus resists phagocytosis in the absence of serum opsonins. Infect. Immun. 49:715-718.
30. Tison, D. L., and M. T. Kelly. 1986. Virulence of Vibrio vulnificus strains from marine environments. Appl. Environ. Microbiol. 51:1004-1006.
31. Wright, A. C., J. L. Powell, M. K. Tanner, L. A. Ensor, A. B. Karpas, J. G. Morris, Jr., and M. B. Sztein. 1999. Differential expression of Vibrio vulnificus capsular polysaccharide. Infect. Immun. 67:2250-2257.
32. Wright, A. C., J. L. Powell, J. B. Kaper, and J. G. Morris, Jr. 2001. Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect. Immun. 69:6893-6901.
33. Yoshida, S., M. Ogawa, and Y. Mizuguchi. 1985. Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect. Immun. 47:446-451.